A Phase 1 interventional study of Voriconazole in Fungal Infection, sponsored by Pfizer. Completed. Open to male participants aged 18 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2009-03-12.
Sponsored by Pfizer · Phase 1 and Interventional
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 17 studies testing voriconazole in Mycoses — none open to participants now, none under way, none of them phase 3. Voriconazole · Mycoses.
Among the 17 studies testing voriconazole in Mycoses, this one is the 15th largest by enrollment, is the only one that started in 2005, is one of 5 in phase 1, and was the 6th registered.
260 studies on the registry are indexed under Mycoses; 37 are open to participants now.
Browse Mycoses studies →None of the 17 studies testing voriconazole in Mycoses is open now. The open studies under Mycoses, anywhere →
Voriconazole: first FDA approval 2002 (VFEND), first EMA approval 2002. What it is approved for, and how studies give it, is on its page →
Of the 24 Mycoses studies recruiting now, 13 (54%) set no upper age limit and 4 (17%) stop at 75 or younger; 5 take children under 18; 6 take healthy volunteers.
This study: 18 Years to 55 Years · male · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
17 studies; the count open now beside each. This study's row is marked.
First in 1997; this study’s year is marked. 1 started in 2005.
This study's enrollment of 12 is below the median of 68 across 164 interventional studies indexed under Mycoses.
Median enrollment 29 across the 17 interventional studies. Of the 17 that completed or were terminated, 7 (41%) have results posted.
This tab as a report to print or save as PDF → With an account.
5 of 17 have an industry lead sponsor. The 10 most frequent:
Pfizer is the lead sponsor of 3,337 studies on the registry; 150 are open to participants now.
Of its 601 completed or terminated interventional studies of FDA-regulated products, 392 (65%) have results posted.
10 studies in Mycoses by Pfizer: none open now, none under way, none of them phase 3. Of 10 finished, 5 (50%) have results posted.
Among the 10 studies in Mycoses by Pfizer, this one is the only one that started in 2005, is the only one in phase 1, and was the 5th registered.
Pfizer’s Mycoses studies by the year they started, since 2005.
None of the studies under way reaches primary completion within a year.
Among the 17 studies testing voriconazole in Mycoses, from their registry updates:
Nothing recorded among them since 2026-09-25.
Among Pfizer’s 10 in Mycoses:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to determine the amount of voriconazole in the brain by fluorine-magnetic resonance spectroscopy (MRS) and to compare brain levels to plasma levels.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Assess brain levels of voriconazole in the brain using a non-evasive technique of MRS
No study locations are listed for this record.
The record gives a start of Apr 2005 and a completion of May 2005. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Mar 2009. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Voriconazole